NASDAQ
Rein Therapeutics Inc. (RNTX) has a fcf yield of -65.60% as of Friday, May 29, 2026. This represents a 65.91% increase compared to its 12-month average of -192.42%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.